Financials
- Market Capitalization 810.43 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.06
Relación precio/flujo de caja
8.48
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2582 | ACHV Achieve Life Sciences, Inc. - Common Shares | 8.10 USD | -0.98% | +1.50% | +28.57% | +175.51% | 833.51 M USD | ||
| 2596 | PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | +16.42% | -14.66% | 820.97 M USD | ||
| 2615 | DBVT DBV Technologies S.A. - American Depositary Shares | 13.54 USD | -6.04% | -5.18% | -1.24% | +42.98% | 801.73 M USD | ||
| 2637 | NVCT Nuvectis Pharma, Inc. - Common Stock | 23.73 USD | -5.80% | +0.72% | +2.64% | +265.08% | 773.16 M USD |